CNTX Q1 2026 Earnings Context Therapeutics Beats EPS Estimates with NarrowerThanExpected Loss Ingram Micro Holding Corporation INGM Q1 2026 Earnings Earnings Beat Driven by Operational Efficiency CVGI Q1 2026 Earnings EPS Beat Delivers Positive Surprise Amid Revenue Disclosures GAINZ Q1 2026 Earnings Modest EPS Miss Reflects Challenging Investment Environment First Citizens BancShares FCNCN Q1 2026 Earnings Strong EPS Beat Amid Stable Preferred Stock Performance OCFC Q1 2026 Earnings EPS Beat of 591 Highlights Resilience Amid Slight Stock Decline MGEE Q1 2026 Earnings EPS Surpasses Estimates on Strong Utility Performance Fulcrum Therapeutics Q1 2026 Earnings Narrowing Losses as Pipeline Advances UMC Q1 2026 Earnings Massive EPS Beat Signals Strong Operational Leverage AEVA Q1 2026 Earnings EPS Beat Driven by Cost Discipline Amid PreRevenue Stage Travere Therapeutics Q1 2026 Earnings WiderthanExpected Loss Stings Shares Day One Biopharmaceuticals DAWN Q4 2025 Earnings EPS Miss Reflects RD Spend Amid PreRevenue Status HeartSciences Inc HSCS Q1 2026 Earnings WiderThanExpected Loss Narrows on Strong Cost Control Shares Rally